Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Iclusig | Statement: [Ariad Pharmaceuticals, ponatinibBrandName, Iclusig]

Target entity: Iclusig
Context triple: [Ariad Pharmaceuticals, ponatinibBrandName, Iclusig]

• A. Venclexta
  Venclexta is a targeted cancer therapy (venetoclax) used primarily to treat certain types of leukemia by inhibiting the BCL-2 protein that helps cancer cells survive.
• B. Imbruvica
  Imbruvica is a targeted cancer therapy (a Bruton's tyrosine kinase inhibitor) used primarily to treat certain types of blood cancers such as mantle cell lymphoma and chronic lymphocytic leukemia.
• C. Onpattro
  Onpattro is an RNA interference (RNAi) therapeutic used to treat polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis.
• D. Verzenio
  Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
• E. Tasigna
  Tasigna is a prescription tyrosine kinase inhibitor used primarily to treat certain types of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in adults and children.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Iclusig
Triple: [Ariad Pharmaceuticals, ponatinibBrandName, Iclusig]

Iclusig is a cancer medication containing ponatinib, primarily used to treat certain types of leukemia such as chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).

Target entity: Iclusig
Target entity description: Iclusig is a cancer medication containing ponatinib, primarily used to treat certain types of leukemia such as chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).

• A. Venclexta
  Venclexta is a targeted cancer therapy (venetoclax) used primarily to treat certain types of leukemia by inhibiting the BCL-2 protein that helps cancer cells survive.
• B. Imbruvica
  Imbruvica is a targeted cancer therapy (a Bruton's tyrosine kinase inhibitor) used primarily to treat certain types of blood cancers such as mantle cell lymphoma and chronic lymphocytic leukemia.
• C. Onpattro
  Onpattro is an RNA interference (RNAi) therapeutic used to treat polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis.
• D. Verzenio
  Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
• E. Tasigna
  Tasigna is a prescription tyrosine kinase inhibitor used primarily to treat certain types of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in adults and children.
• F. None of above. chosen

Target predicate: ponatinibBrandName
Context triple: [Ariad Pharmaceuticals, ponatinibBrandName, Iclusig]

• A. isProdrugOf
  Indicates that one substance is a precursor form that is metabolized in the body to produce the active form of another substance.
• B. isPegylated
  Indicates that a molecule, typically a drug or therapeutic agent, has been chemically modified by the attachment of polyethylene glycol (PEG) chains.
• C. sponsorDrugBrand chosen
  Indicates that one entity financially supports, endorses, or promotes a specific drug brand, typically in a commercial or regulatory context.
• D. hasMolecularTarget
  Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
• E. isIndicatedAsMonotherapyFor
  Indicates that a treatment is recommended or used alone, without combination with other therapies, for a particular condition or purpose.
• F. None of above.